ArticleInternational journal of clinical and experimental pathology2024

Activation of cGAS confers PARP inhibitor resistance in ovarian cancer via the TBK1-IRF3 axis.

Hongxia Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.